[Reevaluation of MAB therapy and progress of endocrine therapy]

Gan To Kagaku Ryoho. 2005 May;32(5):705-28.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / therapeutic use*
  • Anilides / administration & dosage
  • Anilides / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Combined Modality Therapy
  • Goserelin / therapeutic use*
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Male
  • Nitriles
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / surgery
  • Survival Rate
  • Tosyl Compounds

Substances

  • Androgen Antagonists
  • Anilides
  • Antineoplastic Agents, Hormonal
  • Nitriles
  • Tosyl Compounds
  • Goserelin
  • bicalutamide
  • Prostate-Specific Antigen